Inclusion Criteria:
  1. Subject has signed an informed consent form prior to any study-specific procedures being performed
  2. Subject is an ambulatory female at least 18 years of age
  3. Subject agrees to adhere to the study requirements
  4. Subject agrees not to be the primary caregiver of any dependents during the infusion
  5. Subject must have a negative pregnancy test on Day 1 prior to the start of the ZULRESSO infusion
  6. Subject has a current diagnosis of PPD, as assessed by the Investigator
Exclusion Criteria:
  1. Subject has end stage renal disease
  2. Subject has a known allergy to progesterone or allopregnanolone